On December 19, 2022, Franco Palomba provided Accuray Incorporated with notice of his intent to resign from his position as Chief Accounting Officer and principal accounting officer, which resignation will be effective January 3, 2023, due to personal reasons. Mr. Palomba's resignation was not a result of any disagreement with the Company or its Board of Directors, or any matter relating to the Company's operations, policies or practices. On December 21, 2022, the Company's Board of Directors appointed Gina Corradetti, 49, as the Company's Chief Accounting Officer and principal accounting officer, effective January 3, 2023.

Ms. Corradetti joined the Company in December 2022 as Vice President, Controller. Previously, she served as Corporate Controller at Gynesonics Inc., a developer of treatment solutions for uterine conditions, from October 2021. Prior to that, she served as Assistant Corporate Controller of Varian Medical Systems, a manufacturer of medical devices and software for treating cancer and other medical conditions that was acquired by Siemens Healthineers in 2021, from May 2018 through October 2021; Director, Accounting Advisory Services at KPMG LLP, an accounting firm, from November 2014 through May 2018; and has served in various positions, most recently as Senior Manager (Director level), at PricewaterhousCoopers LLP, an accounting firm, from October 1999 through November 2014.

Ms. Corradetti began her career at BDO Dunwoody LLP. Ms. Corradetti received a Bachelor of Business Administration from Wilfrid Laurier University. In connection with her appointment, Ms. Corradetti will enter into the Company's standard indemnification agreement.

Ms. Corradetti will not receive any additional compensation in connection with her appointment. Ms. Corradetti has no family relationships or related party transactions with the Company that would require disclosure under Items 401(d) and 404(a) of Regulation S-K in connection with her appointment.